menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Cardinal expands gastroenterology, diabetes with 2 deals of 3.9 bln

    REUTERS

    Cardinal Health Q1 FY 2025 Results and Raised Outlook

    PR NEWSWIRE

    T2 Biosystems Agreement With Cardinal Health to Sell Blood Diagnostic

    GLOBENEWSWIRE

    Cardinal to acquire Integrated Oncology Network for $1.12 billion

    REUTERS

    Cardinal Health To Acquire Integrated Oncology For $1.12B

    REUTERS

    Telix Announces Names Cardinal Health as US Distributor for Zircaix®

    GLOBENEWSWIRE

    Robbins Geller And Lieff Cabraser Announce $300M Opioid Class Action Settlement

    PR NEWSWIRE

    Cardinal Health Opens New Advanced Therapy Center

    CONTRACT PHARMA

    US FDA sends warning letter to Cardinal Health for marketing unapproved devices

    REUTERS

    Drug distributor Cardinal Health to lose OptumRx contracts

    REUTERS

    Cardinal Health to acquire Specialty Networks and its PPS Analytics platform

    PR NEWSWIRE

    Enforcement Report - Week of November 29, 2023

    FDA

    FDA warns against using Cardinal`s syringes

    REUTERS

    Cardinal lifts FY profit outlook again on strong sales of specialty drugs

    REUTERS

    Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections

    FDA

    FDA advises not to purchase certain eye drops due to infection risk

    REUTERS

    Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health

    BUSINESSWIRE

    Cardinal Health raises annual profit forecast on specialty drug demand

    REUTERS

    Cardinal Health unveils two distribution centers in Central Ohio

    PR NEWSWIRE

    Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2023 on May 4

    PR NEWSWIRE

    Cardinal Health, McKesson prevail in Georgia families` opioid trial

    REUTERS

    Cardinal Teams Up with Palantir to Deliver a Integrated Supply Chain Solution

    PR NEWSWIRE

    Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2023 on Feb2

    PR NEWSWIRE

    U.S. opioid crackdown hampers some patients` access to psychiatric drugs

    REUTERS

    Kroger /Ralphs Pharmacy and Cardinal Health to Host Drug Take Back Events

    PRNEWSWIRE

    Cardinal Health Opioid Derivative Suit Ends With Settlement Nod

    BLOOMBERG

    Cardinal Health Announces Pharmaceutical Segment Organizational Changes

    PRNEWSWIRE

    Cardinal Health Announces Governance Enhancements and Shareholder Value

    PRNEWSWIRE

    Elliott Management Has Large Position in Cardinal Health

    WSJ

    Cardinal Health Announces Leadership Changes

    PRESS RELEASE

    West Virginia cities reach $400 mln opioid distributor settlement

    REUTERS

    Cardinal Health Names Michelle Greene as CIO

    PRNEWSWIRE

    Enforcement Report - Week of May 25, 2022

    FDA

    Opioid distributors reach $518 mln settlement with Washington state

    REUTERS

    J&J, drug distributors finalize $26B opioid settlement

    FIERCEPHARMA

    Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in the U.S.

    PRNEWSWIRE

    Nevada to Join $26B Opioid Settlement With Drug Distributors, J&J

    CLAIMSJOURNAL

    Cardinal Health`s WaveMark launches supply automation solution for clinical labs

    PRNEWSWIRE

    Journey & Cardinal Health OptiFreight Logistics Collaborate for Diabetes Care

    BIOSPACE

    Cardinal Health Biosimilars Expert Discusses Dynamics of Byooviz Launch

    CENTERFORBIOSIMILARS

    FDA slaps Class I label on recall of contaminated ultrasound gel

    FIERCEBIOTECH

    Cardinal Health & others support demand for Ga-68 labeled radiopharmaceuticals

    FIRSTWORDPHARMA

    Six U.S. states do not join $26 bln opioid settlements with distributors, J&J

    REUTERS

    Cardinal Health recalls land back-to-back FDA Class I labels

    FIERCEBIOTECH

    FDA classifies recall of Cardinal Health`s catheter devices as most serious

    REUTERS

    TerraPower, Cardinal Health Enter Manufacturing Agreement

    CONTRACT PHARMA

    TerraPower and Cardinal Health announce agreement for Actinium-225

    WEBWIRE

    Cardinal Health launches tool to help pharmacists understand biosimilar laws

    CHAINDRUGREVIEW

    Cardinal Health launches tool to help pharmacists understand biosimilar laws

    CHAINDRUGREVIEW

    Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. FDA

    PRNEWSWIRE

    Cardinal Health Nuclear & Precision Health Solutions Receives USFDA Approval

    BIOSPACE

    Enforcement Report - Week of June 2, 2021

    FDA

    Cardinal Health to sell its Cordis device division in $1B deal

    FIERCE BIOTECH

    Cardinal Health sells troubled Cordis unit to private equity firm for $1B

    MEDTECHDIVE

    Cardinal Health signs definitive agreement to sell its Cordis business

    BIOSPACE

    Cardinal Health sells troubled Cordis unit to private equity firm for $1B

    MEDTECHDIVE

    Cardinal Health signs definitive agreement to sell its Cordis business

    PRNEWSWIRE

    Cardinal Health, AmerisourceBergen book billions in opioid settlement charges

    REUTERS

    Treasurer Magaziner, CT Treasurer Wooden Urge Shareholders to Reject Bonus

    RI

    Tedor Pharma, Cardinal Health Form Collaboration

    CONTRACTPHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.